Nutrition economics: Are cost-effectiveness data in nutrition a double edged sword for nutrition companies?

Background: Transdiagnostic Cognitive Behaviour Therapy (CBT) seeks to identify core cognitive-behavioural processes hypothesized to be important across a range of disorders and to develop a treatment that targets these. This contrasts with standard CBT approaches that are disorder-specific. Proponents of transdiagnostic CBT suggest that it may offer advantages over disorder-specific CBT, but little is known about the effectiveness of this approach. Aims: The review aimed to summarize trial-based clinical and cost-effectiveness data on transdiagnostic CBT for anxiety and depression. Method: A systematic review of electronic databases, including peer-reviewed and grey literature sources, was conducted (n = 1167 unique citations). Results: Eight trials were eligible for inclusion in the review. There was evidence of an effect for transdiagnostic CBT when compared to a control condition. There were no differences between transdiagnostic CBT and active treatments in two studies. We found no evidence of cost-effectiveness data. Conclusions: Quality assessment of the primary studies indicated a number of methodological concerns that may serve to inflate the observed effects of transdiagnostic approaches. Although there are positive signs of the value of transdiagnostic CBT, there is as yet insufficient evidence to recommend its use in place of disorder-specific CBT.

Download Full-text

M-health for maternal health- bridging the gaps!!

International Journal of Reproduction Contraception Obstetrics and Gynecology ◽

10.18203/2320-1770.ijrcog20175822 ◽

2017 ◽

Vol 7 (1) ◽

pp. 1

Author(s):

Sheeba Marwah ◽

Pratima Mittal

Keyword(s):

Health Care ◽

Cost Effectiveness ◽

Maternal Health ◽

Medical Care ◽

Health Care Providers ◽

Mobile Technology ◽

Clinical Applications ◽

Obstetrics And Gynecology ◽

Care Providers ◽

Effectiveness Data

This article reviews significance, potential and principles to consider when setting up a telemedicine (TM) program to provide care to women in the field of obstetrics and gynecology, essentially deploying mobile technology. There are various benefits of such TM clinical applications. The consensus among patients and health care providers is that this technology is convenient to provide needed subspecialty medical care, even when it is not available locally. Such innovations are clinically successful, but economic and cost-effectiveness data are lacking.

Download Full-text

Diabetes Drugs and Cardiovascular Event Reduction: A Paradigm Shift

US Cardiology Review ◽

10.15420/usc.2017:35:1 ◽

2018 ◽

Vol 12 (1) ◽

pp. 46-50

Author(s):

Erik M Kelly ◽

Donald E Cutlip

Keyword(s):

Clinical Practice ◽

Cost Effectiveness ◽

Paradigm Shift ◽

Cardiovascular Events ◽

Outcome Data ◽

Review Article ◽

Sodium Glucose Cotransporter ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Effectiveness Data

This review article summarizes the recent cardiovascular outcome data for sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 analogues, which have been found to reduce cardiovascular events. We also detail the implications these new medications will have on clinical practice through a review of recent diabetes guidelines and cost-effectiveness data.

Download Full-text

Are cost-effectiveness data used to make NHS decisions?

PharmacoEconomics & Outcomes News ◽

10.2165/00151234-201106290-00011 ◽

2011 ◽

Vol 629 (1) ◽

pp. 4-4

Keyword(s):

Cost Effectiveness ◽

Effectiveness Data

Download Full-text

Feasibility of the implementation of medication reconciliation in Hungary

Orvosi Hetilap ◽

10.1556/oh.2014.29976 ◽

2014 ◽

Vol 155 (35) ◽

pp. 1395-1405

Author(s):

Ádám Freisinger ◽

Judit Lám ◽

Lilla Barki ◽

Márton Király ◽

Éva Belicza

Keyword(s):

Cost Effectiveness ◽

Medication Safety ◽

Medication Reconciliation ◽

Success Factors ◽

Driving Forces ◽

Healthcare Providers ◽

Process Redesign ◽

Safety Improvement ◽

Reconciliation Method ◽

Effectiveness Data

Introduction: For medication safety improvement medication reconciliation was proven to be an effective method transferable between different healthcare providers and ward profiles. Aim: Gaining a better understanding of the process of reconciling medicines. Mapping the driving and restraining forces of introducing medication reconciliation. Method: A search of the literature was conducted. 19 databases were searched using 7 different search engines. The relevance of the papers was rated by two independent experts. Data were extracted based on a previously compiled extraction tool. Results: 230 articles were evaluated. Limits and driving forces of implementing medication reconciliation were set out. Often mentioned implementation obstacles were: communication issues, disengagement of the leaders, unpredictable resources and competence problems. Recommendations mainly consisted of process redesign techniques, presentation of cost-effectiveness data and arranging special training for staff. Conclusions: For improvement of medication safety in Hungarian hospitals implementing medication reconciliation should be considered. The conclusion of ongoing on-site trials as well as limits and success factors identified in this paper should taken into account. Orv. Hetil., 2014, 155(35), 1395–1405.

Download Full-text